Iridium(III)-Catalyzed Tandem Annulation Synthesis of Pyrazolo[1,2-α

Dec 6, 2018 - New science set the tone for the drug industry this year. It can be credited for a wave of investment... SCIENCE CONCENTRATES ...
0 downloads 0 Views 697KB Size
Subscriber access provided by YORK UNIV

Note

Iridium(III)-Catalyzed Tandem Annulation Synthesis of Pyrazolo [1,2-#] Cinnolines from Pyrazolones and Sulfoxonium Ylides Chen-Fei Liu, Man Liu, and Lin Dong J. Org. Chem., Just Accepted Manuscript • DOI: 10.1021/acs.joc.8b02582 • Publication Date (Web): 06 Dec 2018 Downloaded from http://pubs.acs.org on December 7, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 22 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

The Journal of Organic Chemistry

Iridium(III)-Catalyzed Tandem Annulation Synthesis of Pyrazolo [1,2-α] Cinnolines from Pyrazolones and Sulfoxonium Ylides Chen-Fei Liu,+ Man Liu,+ and Lin Dong* Key Laboratory of Drug Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 610041,China [+] These authors contribute equally to the work.

Corresponding author: Lin Dong E-mail:[email protected]

Graphic Abstract

Abstract: A highly efficient iridium-catalyzed cascade annulation of pyrazolones and sulfoxonium ylides to access various pyrazolo [1,2-α] cinnoline derivatives has been achieved. This novel approach expanded the application scope of coupling partners to ylides. The control experiments were performed to give insight to the mechanism of this reaction.

Cinnolines represent an important class of nitrogen-containing heterocycles with diverse biological and pharmacological activities.1 Due to their challenging frameworks and appealing properties, both synthetic and medicinal chemists have been devoted to constructing such heterocycles, but most of the approaches suffer from multistep synthetic processes and the harsh reaction conditions.2 Thus, to fully disclose the pharmacological potential of cinnoline derivatives, efficient and simple synthetic strategies are highly desirable.

1

ACS Paragon Plus Environment

The Journal of Organic Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 22

In view of the advances in transition-metal-catalyzed C–H activation, especially the achievements to construct intricate organic molecules and many natural products, C−H functionalization has emerged as versatile methods in the past few decades.3 Cinnolines have also been studied by many groups via C−H activation.4 However, to our knowledge, there are only a few examples of synthesizing pyrazolo [1,2-α] cinnoline skeleton.5-7 Huang and Lin et al utilized pyrazolidinones to construct such a unit (Scheme 1, eqs 1 and 2).6a,7b Very recently, Zhang et al reported an alternative synthesis of cinnoline complex through rhodium-catalyzed oxidative coupling of N-aryl-1H-pyrazol5(4H)-ones with various alkynes (Scheme 1, eq 3).5 It is generally known that 3-methyl-1-phenyl-1H-pyrazol5(4H)-one as a new pyrazolin compound namely Edaravone also known as MCI-186 is the first novel neuroprotective, antioxidant medical drug. In addition, pyrazole units have also been widely implicated in pharmaceutical molecules (Figure 1).8,9

Figure 1. Drugs Bearing Pyrazole Units

Therefore, this unique unit of pyrazolo [1,2-α]cinnoline derivatives has aroused our great interest, which might have more potential application value and activities. Herein, we described a novel approach to access wider pyrazolo [1,2-α] cinnoline derivatives via iridium(III)-catalyzed tandem annulation between 3-methyl-1-phenyl-1H-pyrazol5(4H)-ones and sulfoxonium ylides (Scheme 1, eq 4).10

2

ACS Paragon Plus Environment

Page 3 of 22 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

The Journal of Organic Chemistry

Scheme 1. Synthesis of Cinnolines via C−H Activation

We commenced our investigation with the screening of reaction parameters for the coupling of 3-methyl-1phenyl-1H-pyrazol-5(4H)-one (1a) and sulfoxonium ylide (2a) (Table 1). In the presence of a catalytic amount of [IrCp*Cl2]2 (5 mol %) and Zn(OTf)2 (0.5 equiv) in TFE at 120 °C for 12 h, the desired product 3aa was obtained, although albeit in a low yield (entries 1-4). To our delight, the addition of silver salts could effectively enhance the reaction activity and AgSbF6 turned out to be the optimal one (entries 5–8). It is noteworthy to mention, the reaction afforded negative efficiency in the absence of Zn(OTf)2 (entries 9 and 10). However, other solvents including DCE and several proton solvents were less active giving 3aa in lower yields (entries 11–14). Satisfyingly, further introduction of TsOH into the reaction system intensively improved the yield of 3aa to 92% (entries 15-17). Decreasing the loading of Zn(OTf)2 resulted in a higher yield (entry 18). In contrast, an inferior yield was observed by reducing the amount of TsOH (entry 19). In addition, 67% yield was obtained by using polar aprotic solvent CH3CN (entry 20). Moreover, decreasing the temperature gave inferior result (entry 21). In addition, different material ratio gave relatively low yield (entry 22). In addition, to evaluate the synthetic potential of this methodology, a gram scale reaction of 3aa was carried out: 1a (6 mmol) smoothly reacted with sulfoxonium ylide 2a (4 mmol), affording the desired product 3aa still in good yield (entries 23 and 24). Table 1. Optimization of the Reaction Conditionsa

3

ACS Paragon Plus Environment

The Journal of Organic Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 22

entry

catalyst

additive/[equiv.]

acid/[equiv.]

solvent

yield b (%)

1

[Cp*IrCl2]2

Zn(OTf)2/0.5

-

TFE

26

2

[Cp*RhCl2]2

Zn(OTf)2/0.5

-

TFE

15

3

[Cp*CoCl2]2

Zn(OTf)2/0.5

-

TFE

ND

4

Ru(PPh3)3Cl2

Zn(OTf)2/0.5

-

TFE

ND

5

[Cp*IrCl2]2

AgBF4/0.2 + Zn(OTf)2/0.5

-

TFE

ND

6

[Cp*IrCl2]2

AgSbF6/0.2 + ZnOTf)2/0.5

-

TFE

70

7

[Cp*IrCl2]2

AgNTf2/0.2 + Zn(OTf)2/0.5

-

TFE

43

8

[Cp*IrCl2]2

AgOTf /0.5 + Zn(OTf)2/0.5

-

TFE

63

9

[Cp*IrCl2]2

AgSbF6/0.2 + Zn(OAc)22H2O/0.5

-

TFE

ND

10

[Cp*IrCl2]2

AgSbF6/0.2 + AgOTf/0.5

-

TFE

42

11

[Cp*IrCl2]2

AgSbF6/0.2 + Zn(OTf)2/0.5

-

DCE

37

12

[Cp*IrCl2]2

AgSbF6/0.2 + Zn(OTf)2/0.5

-

HFIP

54

13

[Cp*IrCl2]2

AgSbF6/0.2 + Zn(OTf)2/0.5

-

MeOH

ND

14

[Cp*IrCl2]2

AgSbF6/0.2 + Zn(OTf)2/0.5

-

t-BtOH